Clinical Trial Update: Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining brain plasticity and a GLP-1 receptor agonist for obesity; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: University of Colorado, Denver | Conditions: Obesity/Therapy | Phase 3 | Status: NOT_YET_RECRUITING